Olbia Serra
L'hospitalet De Llobregat, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Prospective Exploratory Analysis of Angiogenic Biomarkers in Peripheral Blood in Advanced NSCLC Patients Treated With Bevacizumab Plus Chemotherapy: The ANGIOMET Study.
Journal: Frontiers in oncology
Published: April 14, 2021
External validity of clinical trials with diverse trastuzumab-based chemotherapy regimens in advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry.
Journal: Therapeutic advances in medical oncology
Published: February 13, 2021
Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: November 25, 2020
Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry.
Journal: PloS one
Published: April 06, 2020
Progress and challenges in gastroesophageal cancer.
Journal: Current problems in cancer
Published: February 19, 2020
Comparison and applicability of molecular classifications for gastric cancer.
Journal: Cancer treatment reviews
Published: March 04, 2019
Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 18, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026